Karl Hård
Investor Relations Contact bij EGETIS THERAPEUTICS AB
Actieve functies van Karl Hård
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Investor Relations Contact | 01-02-2022 | - |
| Public Communications Contact | 01-02-2022 | - |
Loopbaan van Karl Hård
Eerdere bekende functies van Karl Hård
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 05-09-2017 | 31-12-2018 |
| Public Communications Contact | 05-09-2017 | 31-12-2018 | |
| REDX PHARMA PLC | Investor Relations Contact | 08-09-2016 | 02-07-2017 |
| Public Communications Contact | 08-09-2016 | 02-07-2017 | |
| University of Leiden | Corporate Officer/Principal | - | - |
| ASTRAZENECA PLC | Public Communications Contact | - | - |
Opleiding van Karl Hård
| University of Utrecht | Doctorate Degree |
| University of Helsinki | Graduate Degree |
Statistieken
Internationaal
| Nederland | 4 |
| Verenigd Koninkrijk | 3 |
| Finland | 2 |
Operationeel
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| REDX PHARMA PLC | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
